About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.20 (-9.30%)
AGNASXArgenica Therapeutics Ltd
Loading watchlist status…
Argenica Therapeutics Ltd share price
AGN price activity
Last Price
Change (24hr)
AUD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
AGN price performance
-4,88%
5D
34,48%
1M
-33,9%
YTD
-71,32%
1Y
AGN price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
AU-ASX rank
N/ASector Rank
N/Aquote.marketSignals